Literature DB >> 18339768

Neural stem cell targeting of glioma is dependent on phosphoinositide 3-kinase signaling.

Stephen E Kendall1, Joseph Najbauer, Heather F Johnston, Marianne Z Metz, Shan Li, Marisa Bowers, Elizabeth Garcia, Seung U Kim, Michael E Barish, Karen S Aboody, Carlotta A Glackin.   

Abstract

The utility of neural stem cells (NSCs) has extended beyond regenerative medicine to targeted gene delivery, as NSCs possess an inherent tropism to solid tumors, including invasive gliomas. However, for optimal clinical implementation, an understanding of the molecular events that regulate NSC tumor tropism is needed to ensure their safety and to maximize therapeutic efficacy. We show that human NSC lines responded to multiple tumor-derived growth factors and that hepatocyte growth factor (HGF) induced the strongest chemotactic response. Gliomatropism was critically dependent on c-Met signaling, as short hairpin RNA-mediated ablation of c-Met significantly attenuated the response. Furthermore, inhibition of Ras-phosphoinositide 3-kinase (PI3K) signaling impaired the migration of human neural stem cells (hNSCs) toward HGF and other growth factors. Migration toward tumor cells is a highly regulated process, in which multiple growth factor signals converge on Ras-PI3K, causing direct modification of the cytoskeleton. The signaling pathways that regulate hNSC migration are similar to those that promote unregulated glioma invasion, suggesting shared cellular mechanisms and responses. Disclosure of potential conflicts of interest is found at the end of this article.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18339768     DOI: 10.1634/stemcells.2007-0887

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  41 in total

1.  Endogenous expression of matriptase in neural progenitor cells promotes cell migration and neuron differentiation.

Authors:  Jung-Da Fang; Hsiao-Chin Chou; Hsiu-Hui Tung; Pao-Yi Huang; Sheau-Ling Lee
Journal:  J Biol Chem       Date:  2010-12-13       Impact factor: 5.157

Review 2.  Gene therapy and virotherapy: novel therapeutic approaches for brain tumors.

Authors:  Kurt M Kroeger; A K M Ghulam Muhammad; Gregory J Baker; Hikmat Assi; Mia K Wibowo; Weidong Xiong; Kader Yagiz; Marianela Candolfi; Pedro R Lowenstein; Maria G Castro
Journal:  Discov Med       Date:  2010-10       Impact factor: 2.970

Review 3.  Human nerual stem cells for brain repair.

Authors:  Seung U Kim; Hong J Lee; In H Park; Kon Chu; Soon T Lee; Manho Kim; Jae K Roh; Seung K Kim; Kyu C Wang
Journal:  Int J Stem Cells       Date:  2008-11       Impact factor: 2.500

Review 4.  Novel treatment strategies for malignant gliomas using neural stem cells.

Authors:  Michael C Oh; Daniel A Lim
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

5.  Anti-YKL-40 antibody and ionizing irradiation synergistically inhibit tumor vascularization and malignancy in glioblastoma.

Authors:  Rong Shao; Ralph Francescone; Nipaporn Ngernyuang; Brooke Bentley; Sherry L Taylor; Luis Moral; Wei Yan
Journal:  Carcinogenesis       Date:  2013-11-26       Impact factor: 4.944

6.  The Potentials and Pitfalls of Using Adult Stem Cells in Cancer Treatment.

Authors:  Mrinal K Das; Taral R Lunavat; Hrvoje Miletic; Jubayer A Hossain
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Neural stem cells improve intracranial nanoparticle retention and tumor-selective distribution.

Authors:  Rachael Mooney; Yiming Weng; Revathiswari Tirughana-Sambandan; Valerie Valenzuela; Soraya Aramburo; Elizabeth Garcia; Zhongqi Li; Margarita Gutova; Alexander J Annala; Jacob M Berlin; Karen S Aboody
Journal:  Future Oncol       Date:  2014-02       Impact factor: 3.404

Review 8.  Stem cells as vectors to deliver HSV/tk gene therapy for malignant gliomas.

Authors:  Prakash Rath; Huidong Shi; Joel A Maruniak; N Scott Litofsky; Bernard L Maria; Mark D Kirk
Journal:  Curr Stem Cell Res Ther       Date:  2009-01       Impact factor: 3.828

Review 9.  Applications of neural and mesenchymal stem cells in the treatment of gliomas.

Authors:  Thomas Kosztowski; Hasan A Zaidi; Alfredo Quiñones-Hinojosa
Journal:  Expert Rev Anticancer Ther       Date:  2009-05       Impact factor: 4.512

10.  Iron labeling and pre-clinical MRI visualization of therapeutic human neural stem cells in a murine glioma model.

Authors:  Mya S Thu; Joseph Najbauer; Stephen E Kendall; Ira Harutyunyan; Nicole Sangalang; Margarita Gutova; Marianne Z Metz; Elizabeth Garcia; Richard T Frank; Seung U Kim; Rex A Moats; Karen S Aboody
Journal:  PLoS One       Date:  2009-09-29       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.